Book a Call

Please enable JavaScript in your browser to complete this form.
Name
By signing up, you agree to receive emails and communications from SEBERS Medical. Unsubscribe anytime.
Edit Template

INTRODUCING THE BLOSSOM BURST MAGAZINE


Get the Blossom Burst delivered right into your inbox!

tms blossom burst magazine

Sign up for the latest issue of Blossom Burst, where you’ll find interviews with experts, patient case studies, the latest research and practical tips for integrating TMS into mental health care.

* indicates required
Please send me a FREE printed magazine

By signing up, you agree to receive emails and communications from SEBERS Medical. Unsubscribe anytime.

Stay informed, inspired, and connected with the Blossom Burst magazine, the magazine for TMS leadership. Specifically designed for B2B industry professionals, our quarterly publication is packed with valuable insights, expert advice, and inspiring stories to help you stay at the forefront of mental health care. Here’s what you can expect from TMS Blossom Burst Magazine:

  • Thought Leadership: Gain insights from leading experts in TMS therapy and mental health care.
  • Expert Articles: Learn about the latest advancements in rTMS therapy and other mental health treatments.
  • Industry Trends: Stay ahead with the latest trends and developments in the TMS industry.
  • Case Studies: Explore detailed case studies showcasing successful implementations and outcomes of TMS therapy.
  • Research Highlights: Access summaries of cutting-edge research and studies in the field of mental health and TMS.
  • Exclusive Updates: Be the first to know about new services, upcoming events, and special offers at Blossom TMS.

CONTACT INFO

Phone: 833.3BUY.TMS (+1.833.3289.867)

Email: Sales@sebersmedical.com

Address: 230 S Broad Street, 17th Floor Philadelphia, PA 19102

QUICK LINKS

LEGAL

Disclaimer:

Regulations in the United States

*United States Federal Law regulates the sale of Medical Devices. The Blossom TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. (K220625) All other devices on this website are not approved and/or cleared for use in treatment and/or diagnosis in the United States. All investigational devices must be labeled in accordance with the labeling requirements of the IDE regulation (§ 812.5) and bear a label that states:
“CAUTION.
Investigational Device. Restricted by federal (or United States) law to research use.”